real-world

Original Contribution

Auryon Laser in Peripheral Arterial Interventions: A Single-Center Experience (Auryon-SCE)

05/11/2022

Grace Halupnik , MD;

Nicholas Fedele , MD;

Katie Comp , MD;

Emma-Marie Taleb , MD;

Andrew N. Shammas , BS , OMS, MD;

Susan Jones-Miller , MD, MS;

Venkat Shankarraman , MD, PhD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Gail A. Shammas , BSN, BS , RN, BSc;

The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...

The Auryon 355-nm laser...

05/11/2022

Journal of Invasive Cardiology

How Clinical Pathways Are Growing

06/16/2020

In this new series, Journal of Clinical Pathways features insights from the editorial advisory board members pertaining to a specific question on pathways or value-based care.  For the first edition of Ask the...

In...

06/16/2020

Journal of Clinical Pathways

$Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States$

Research Reports

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States

02/18/2020

Andrew J. Klink , PhD, MPH;

Anna G. Purdum , PharmD, MS;

Chadi Nabhan , MD, MBA, FACP;

Bruce A. Feinberg , DO;

Choo Hyung Lee , MS;

Yin Yang , MS;

JaLyna Laney , RN, OCN;

Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...

...

02/18/2020

Journal of Clinical Pathways